ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
587 hedge funds and large institutions have $25.3B invested in Alexion Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 225 increasing their positions, 209 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
16% less capital invested
Capital invested by funds: $30B → $25.3B (-$4.75B)
Holders
587
Holding in Top 10
17
Calls
$420M
Puts
$468M
Top Buyers
| 1 | +$165M | |
| 2 | +$150M | |
| 3 | +$126M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$86.7M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
+$84.1M |
Top Sellers
| 1 | -$162M | |
| 2 | -$154M | |
| 3 | -$152M | |
| 4 |
TP
Third Point
New York
|
-$140M |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
-$117M |